User profiles for Valeriane Leroy

Valériane Leroy

Inserm, Université Toulouse 3
Verified email at inserm.fr
Cited by 12916

Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus …

…, G Peytavin, H Toure, H Menan, V Leroy… - Journal of infectious …, 2006 - academic.oup.com
The frequency of resistance mutations was estimated in the cohort of Agence Nationale de
Recherches sur le SIDA Ditrame Plus, a study that evaluated the combination of shortcourse …

International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection

V Leroy, ML Newell, F Dabis, C Peckham… - The Lancet, 1998 - thelancet.com
Background An understanding of the risk and timing of mother-to-child transmission of HIV-1
in the postnatal period is important for the development of public-health strategies. We …

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa

V Leroy, JM Karon, A Alioum, ER Ekpini, N Meda… - Aids, 2002 - journals.lww.com
Objective To assess the 24 month efficacy of a maternal short-course zidovudine regimen to
prevent mother-to-child transmission (MTCT) of HIV-1 in a breastfeeding population in West …

Transition from paediatric to adult care of adolescents living with HIV in sub‐Saharan Africa: challenges, youth‐friendly models, and outcomes

…, S Ayaya, MA Davies, V Leroy - Journal of the …, 2017 - Wiley Online Library
Introduction: The number of adolescents with perinatally or behaviourally acquired HIV is
increasing in low‐income countries, and especially in sub‐Saharan Africa where HIV …

[PDF][PDF] The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

AL Slogrove, M Schomaker, MA Davies, P Williams… - 2018 - api.scienceportal.msf.org
Background Globally, the population of adolescents living with perinatally acquired HIV (APHs)
continues to expand. In this study, we pooled data from observational pediatric HIV …

Natural history of human immunodefiency virus type 1 infection in children: a five-year prospective study in Rwanda

…, P Lepage, P Msellati, P Van de Perre, V Leroy… - …, 1999 - publications.aap.org
Objective. To compare morbidity and mortality of human immunodeficiency virus type 1 (HIV-1)-infected
and HIV-1-uninfected children and to identify predictors of acquired …

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 …

…, TDA Tony, C Danel, X Anglaret, V Leroy… - Journal of clinical …, 2005 - Am Soc Microbiol
There is an urgent need for low-cost human immunodeficiency virus type 1 (HIV-1) viral
load (VL) monitoring technologies in resource-limited settings. An automated TaqMan real-time …

[HTML][HTML] Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions

…, KA Freedberg, RP Walensky, V Leroy - BMC medicine, 2011 - Springer
Early infant diagnosis (EID) of HIV-1 infection confers substantial benefits to HIV-infected
and HIV-uninfected infants, to their families, and to programs providing prevention of mother-to-…

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and …

…, N Meda, C Welffens-Ekra, B You, O Manigart, V Leroy… - The Lancet, 1999 - thelancet.com
Background Zidovudine reduces the rate of vertical transmission of HIV in non-breastfed
populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short regimen …

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

…, R Thiebaut, B Masquelier, V Leroy… - International journal …, 2007 - academic.oup.com
Background Single-dose nevirapine (NVP) is the main option for the prevention of mother-to-child
transmission (PMTCT) of HIV-1 in countries with limited resources. However, the use …